Management of COPD Exacerbations with Influenza A

Antibiotic Selection

• The British Thoracic Society recommends co-amoxiclav (Augmentin) as the preferred first-line antibiotic for COPD exacerbations during influenza, due to its coverage of common pathogens such as S. pneumoniae, H. influenzae, M. catarrhalis, and S. aureus 1, 2, 3, 4
• Co-amoxiclav 625 mg three times daily is the recommended regimen, with doxycycline as an alternative for patients intolerant of beta-lactams 1, 2, 3, 4
• Macrolides, including azithromycin, are not recommended as first-line therapy due to concerns about antimicrobial resistance and inferior coverage of H. influenzae 1, 2, 3, 4

Treatment Duration and Adjunctive Therapy

• The recommended duration of antibiotic therapy is 5-7 days 5, 6
• Systemic corticosteroids, such as prednisone 40 mg daily for 5 days, should be added to antibiotic therapy for patients with COPD exacerbations 5, 6

Avoiding Common Pitfalls

• Antibiotics should not be routinely combined without evidence of treatment failure or severe pneumonia requiring broader coverage 1, 2, 3, 4
• Azithromycin should not be used as first-line therapy when co-amoxiclav is appropriate and tolerated 1, 2, 3, 4
• Macrolides should be avoided if the patient can tolerate beta-lactams, due to resistance concerns and inferior H. influenzae coverage 1, 2, 3, 4